TrialJournal of the Pediatric Infectious Diseases Society2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19.
Thomas D Norton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.